- Transcatheter Arterial Chemoembolization Plus ¹³¹I-Labelled Metuximab versus Transcatheter Arterial Chemoembolization Alone in Intermediate/Advanced Stage Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
-
Zhu ZX, Liao MH, Wang XX, Huang JW
- KMID: 2466285
- Korean J Radiol.
- 2016 Dec;17(6):882-892.
- doi: 10.3348/kjr.2016.17.6.882
OBJECTIVE: The aim of the study was to compare transcatheter arterial chemoembolization (TACE) plus ¹³¹I-labelled metuximab with TACE alone for hepatocellular carcinoma (HCC). MATERIALS AND METHODS: A comprehensive search was conducted... -
- CITED
-
- Close
- SHARE
-
- Close
- Transcatheter Arterial Chemoembolization for Infiltrative Hepatocellular Carcinoma: Clinical Safety and Efficacy and Factors Influencing Patient Survival
-
Han K, Kim JH, Yoon HM, Kim EJ, Gwon DI, Ko GY, Yoon HK, Ko HK
- KMID: 1731050
- Korean J Radiol.
- 2014 Aug;15(4):464-471.
- doi: 10.3348/kjr.2014.15.4.464
OBJECTIVE: To evaluate the safety and efficacy of transcatheter arterial chemoembolization (TACE) in patients with infiltrative hepatocellular carcinoma (HCC) and to identify the prognostic factors associated with patient survival. MATERIALS AND... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation
-
Lee JY, Kim YH, Yi NJ, Kim HS, Lee HS, Lee BK, Kim H, Choi YR, Hong G, Lee KW, Suh KS
- KMID: 1788569
- Clin Mol Hepatol.
- 2014 Jun;20(2):192-203.
- doi: 10.3350/cmh.2014.20.2.192
BACKGROUND/AIMS: The most commonly used immunosuppressant therapy after liver transplantation (LT) is a combination of tacrolimus and steroid. Basiliximab induction has recently been introduced; however, the most appropriate immunosuppression for... -
- CITED
-
- Close
- SHARE
-
- Close
- Concurrent Chemoradiotherapy Shows Long-Term Survival after Conversion from Locally Advanced to Resectable Hepatocellular Carcinoma
-
Lee IJ, Kim JW, Han KH, Kim JK, Kim KS, Choi JS, Park YN, Seong J
- KMID: 2070195
- Yonsei Med J.
- 2014 Nov;55(6):1489-1497.
- doi: 10.3349/ymj.2014.55.6.1489
PURPOSE: For locally unresectable hepatocellular carcinoma (HCC) patients, concurrent chemoradiotherapy (CCRT) has been applied as a loco-regional treatment. After shrinkage of tumors in selected patients, surgical resection is performed. The... -
- CITED
-
- Close
- SHARE
-
- Close
- Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma
-
Song MJ, Bae SH, Lee JS, Lee SW, Song DS, You CR, Choi JY, Yoon SK
- KMID: 2373799
- Korean J Intern Med.
- 2016 Mar;31(2):242-252.
- doi: 10.3904/kjim.2015.112
BACKGROUND/AIMS: We compared the recurrence of hepatocellular carcinoma (HCC) and the survival of patients who received radiofrequency ablation (RFA) after transarterial chemoembolization (TACE) with patients treated with TACE or RFA... -
- CITED
-
- Close
- SHARE
-
- Close
